mass spectrometry raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-04-15 and is reviewed periodically as new material appears.
Chemically, dihexa is a short peptide-like molecule with nonstandard components. Its structure includes tyrosine and isoleucine residues linked to a hexanoic acid group and an aminohexanoic amide segment. This design distinguishes it from endogenous angiotensin IV, though the two are discussed together because of shared origins. Published summaries classify it as a small synthetic peptide with lipophilic features that may influence how it crosses biological barriers in experimental systems. Exact conformational details depend on the specific salt or free base form.
Regulatory treatment varies by country. Dihexa does not appear in major pharmacopeias as a licensed therapeutic substance. Suppliers may use labels such as research use only or not for human consumption. Such labels reflect legal and quality-control boundaries rather than evidence of clinical benefit. Importation, possession, and sale can be restricted depending on local laws, and enforcement focuses on claims, distribution channels, and product categories. These rules can change, and they differ from rules for approved medicines.
Dihexa is a synthetic peptide studied in preclinical neuroscience. It is often described as an angiotensin IV analog or derivative. The compound also appears under research codes such as PNB-0408 and N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. It is not an approved drug, and it is not a conventional vitamin or nutrient. In many jurisdictions, material sold as dihexa is handled as a research chemical rather than a medicine or supplement. This classification affects how the material is labeled and distributed.
Dihexa appears in scientific literature, patent documents, and commercial catalogs under several names, which can complicate searching and verification. The compound is frequently grouped with nootropics or research chemicals, terms that describe context of use rather than regulatory approval. Such labeling may imply benefits that have not been confirmed in controlled human studies. Readers encountering promotional descriptions should distinguish between preclinical observations and established medical facts. The absence of regulatory approval is a central feature of its current status.
Dihexa is a synthetic peptide-like compound studied in preclinical research for its reported effects on synaptic growth and cognitive measures in animal models. It is often described as an analog of angiotensin IV, a naturally occurring peptide fragment. The compound has not been approved as a medicine in any major jurisdiction. Most public information comes from laboratory studies, patents, and online vendor listings rather than from large clinical trials. Its scientific status therefore differs from that of an established pharmaceutical.
Research interest in dihexa centers on its ability to promote synapse formation in cultured neurons and in some rodent experiments. These findings have been interpreted as a possible mechanism for learning and memory effects, but the evidence remains preliminary. Independent replication is limited, and study designs vary widely in species, duration, and outcome measures. Human data are scarce, so claims about cognitive enhancement in people are not supported by robust clinical evidence. The gap between laboratory signals and proven clinical benefit is substantial.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide analog | Modeled on angiotensin IV |
| Common synonyms | PNB-0408; N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide | Research codes vary by supplier |
| Appearance | White to off-white powder | Typical for lyophilized peptides |
| Solubility | Soluble in organic solvents; limited in water | Formulation dependent |
| Typical storage | −20 °C, desiccated, protected from light | Stability depends on purity and container |
Regulatory status varies by country, and dihexa is not widely approved as a medicine. In many jurisdictions it is treated as a research chemical, which limits its legal sale, possession, and human use. Products marketed online may lack verified purity or identity, and labels can be inaccurate. Researchers typically source material from suppliers that provide analytical documentation and follow institutional safety rules. Open questions remain about long-term stability, metabolite formation, and human pharmacokinetics.
Dihexa is typically supplied as a lyophilized powder for laboratory research. Lyophilization removes water and improves stability during transport and storage. The solid is commonly stored at -20 °C or lower, desiccated, and protected from light. Repeated freeze-thaw cycles and exposure to moisture can degrade peptides, so aliquoting and sealed containers are standard practice in most laboratory settings. These handling measures apply to research-grade material and do not imply clinical suitability.
Identity and purity are usually assessed with reverse-phase high-performance liquid chromatography and mass spectrometry. These methods can separate related impurities and confirm molecular mass, but they do not by themselves establish biological activity. Certificate of analysis documents may report purity as a percentage by area, yet the exact meaning can vary between laboratories. Independent testing can check for residual solvents, counterions, or microbial contamination when relevant. For research use, matching analytical records to a specific lot helps trace experimental variability.
Dihexa occupies an uncertain regulatory space in many countries. It is not generally listed as an approved therapeutic, and some jurisdictions may treat it as a research chemical, a compounded substance, or an unapproved new drug depending on claims and distribution. Importation can be restricted, and suppliers may require documentation that the material is for laboratory research only. Quality and labeling vary, so buyers should request analytical data, verify lot numbers, and understand local rules. These factors make sourcing and compliance part of the practical context around dihexa.
Lyophilized dihexa is typically stored as a dry powder at or below minus twenty degrees Celsius. Cooler temperatures slow degradation, and desiccant protection limits moisture uptake. Repeated temperature cycling can accelerate breakdown, so aliquoting before storage is common in laboratory practice. Solutions are generally less stable than dry powder and are often kept cold, protected from light, and used within a defined period. Specific stability data for dihexa are limited, and handling recommendations often follow general peptide guidelines rather than compound-specific studies.
Human data for dihexa remain absent from peer-reviewed clinical literature. As a result, questions about absorption, distribution, metabolism, excretion, and long-term safety are unresolved. Discussions often appear in nootropic forums, where anecdotal reports cannot substitute for controlled trials. Researchers have called for more rigorous pharmacokinetic and toxicological studies before any clinical evaluation. Until such data exist, dihexa is best described as an investigational research compound rather than a proven intervention.
The proposed mechanism for dihexa centers on hepatocyte growth factor, or HGF, and its receptor c-Met. HGF signaling is involved in cell growth, survival, and synapse formation. Dihexa has been described as an HGF mimetic or modulator in preclinical literature. Whether it binds c-Met directly, increases HGF availability, or acts through another route remains uncertain. This mechanistic uncertainty is a recurring theme in reviews of the compound, and no single molecular model has been confirmed across independent laboratories.
== Honey bees == Honey bees deposit vitellogenin molecules in fat bodies in their abdomen and heads. The fat bodies apparently act as a food storage reservoir. The glycolipoprotein vitellogenin has additional functionality as it acts as an antioxidant to prolong Queen bee and forager lifespan as well as a hormone that affects future foraging behavior. The health of a honey bee colony is dependent upon the vitellogenin reserves of the nurse bees – the foragers having low levels of vitellogenin. As expendable laborers, the foragers are fed just enough protein to keep them working their risky task of collecting nectar and pollen. Vitellogenin levels are important during the nest stage and thus influence honey bee worker division of labor. A nurse bee's vitellogenin titer that developed in the first four days after emergence, affects its subsequent age to begin foraging and whether it preferentially forages for nectar or pollen. If young workers are short on food their first days of life, they tend to begin foraging early and preferentially for nectar. If they are moderately fed, they forage at normal age preferentially for nectar. If they are abundantly fed, immediately after emergence, their vitellogenin titer is high and they begin foraging later in life, preferentially collecting pollen. Pollen is the only available protein source for honey bees.
The club, like most other organizations in Germany, including sports and football clubs, was dissolved by the occupying Allied authorities in the aftermath of the war. Club members reconstituted the team in 1946 as SG Probstheida under the auspices of the occupying Soviets. After playing as BSG Erich Zeigner Probstheida and then BSG Einheit Ost, the club merged with sports club SC Rotation Leipzig in 1954 and played in the DDR-Oberliga, East Germany's top-flight league, but earned only mediocre results. In 1963, the city of Leipzig's two most important sports clubs, SC Rotation and SC Lokomotive Leipzig, were merged, resulting in the founding of two new sides: SC Leipzig and BSG Chemie Leipzig.
The EPA have some regulations and guidelines for monitoring nitrogen dioxide levels. Historically, some states in the US including Chicago, Northeast corridor and Los Angeles have had high levels of nitrogen dioxide. In 2006, the WHO estimated that over 2 million deaths result annually from air pollution in which nitrogen dioxide constitute one of the pollutants. While over 50% of the disease that results from these pollutants are common in developing countries and the effects in developed countries is also significant. An EPA survey in the US suggests that 16 percent of United States' housing units are sited close to an airport, highway or railroad increasing in the United States the exposure risk of approximately 48 million people. A feasibility study of the ozone formed from the oxidation of nitrogen dioxide in ambient air reported by the WHO suggested that daily deaths of 1 to 2% is attributed to exposure to ozone concentration above 47.3 ppb and exposure above 75.7 ppb is attributed to 3 to 5% increase in daily mortality. A level of 114 ppb was attributed to 5 to 9% increase daily mortality. Silo filler's disease is pervasive during the harvest seasons of food grains. In May 2015, the National Green Tribunal directed Delhi and other states in India to ban diesel vehicles over 10 years old as a measure to reduce nitrogen dioxide emission that may result in nitrogen dioxide poisoning. In 2008, the report of United Kingdom Committee on the Medical Effects of Air Pollutants (COMEAP) suggested that air pollution is the cause of about 29,000 deaths in UK.
Senate delegation to visit China during the second Trump presidency, with the group traveling to Beijing and Shanghai to meet Chinese officials and visit technology companies. On 7 May, Chinese premier Li Qiang and National People's Congress Standing Committee chairman Zhao Leji separately met with the delegation in Beijing.
Composition C-4 exists in the U.S. Army Hazardous Components Safety Data Sheet on sheet number 00077. Impact tests done by the U.S. military indicate composition C-4 is less sensitive than composition C-3 and is fairly insensitive. The insensitivity is attributed to using a large amount of binder in its composition. A series of shots were fired at vials containing C-4 in a test referred to as "the rifle bullet test". Only 20% of the vials burned, and none exploded. While C-4 passed the Army's bullet impact and fragment impact tests at ambient temperature, it failed the shock stimulus, sympathetic detonation and shaped charge jet tests. Additional tests were done including the "pendulum friction test", which measured a five-second explosion temperature of 263 °C to 290 °C. The minimum initiating charge required is 0.2 grams of lead azide or 0.1 grams of tetryl. The results of 100 °C heat test are: 0.13% loss in the first 48 hours, no loss in the second 48 hours, and no explosions in 100 hours. The vacuum stability test at 100 °C yields 0.2 cubic centimeters of gas in 40 hours. Composition C-4 is essentially nonhygroscopic. The shock sensitivity of C-4 is related to the size of the nitramine particles. The finer they are the better they help to absorb and suppress shock.
Sources: en.wikipedia.org
Meloxicam blocks cyclooxygenase (COX), the enzyme responsible for converting arachidonic acid into prostaglandin H2—the first step in the synthesis of prostaglandins, which are mediators of inflammation. Meloxicam has been shown, especially at low therapeutic doses, to selectively inhibit COX-2 over COX-1. X-ray crystallographic analyses and molecular modelling studies of meloxicam´s binding to cyclooxygenase isoforms showed that the methyl group of the thiazole ring in meloxicam exploits the "flexible extra space" at the top of the COX-2 channel. The substitution of the second shell amino acid residue Ile434 in COX-1 by Val in COX-2 allows the side chain of Phe518 (a residue at the active side) to open "extra space", which favors the binding of meloxicam to COX-2. Site-directed mutagenesis studies in which Ile434 was substituted for Val434 in COX-2 confirmed this hypothesis. Other oxicams also occupy this binding site, albeit nonselectively because of the missing methyl group in the side chain. Meloxicam concentrations in synovial fluid range from 40% to 50% of those in plasma. The free fraction in synovial fluid is 2.5 times higher than in plasma, due to the lower albumin content in synovial fluid compared to plasma. The significance of this penetration is unknown, but it may account for the fact that it performs exceptionally well in treatment of arthritis in animal models.
12 April The Scottish Government announces it will mount a legal challenge against the UK government's decision to block the Gender Recognition Reform (Scotland) Bill. SNP leader Humza Yousaf confirms that his party will not pay any legal fees for former chief executive Peter Murrell, but that he will not be suspended from the party because he is "innocent until proven guilty". 13 April – Representatives from BBC Scotland, STV, Viaplay and the Scottish FA meet to discuss the broadcasting of men's football in Scotland, the rights of which are owned by Viaplay until 2028. The meeting, to discuss showing free-to-air matches, ends without resolution, but is described by Gavin Newlands MP as encouraging. 15 April – The SNP's National Executive Committee orders a review of the party's transparency and governance. Corach Rambler, trained in Scotland at Milnathort by Lucinda Russell, wins the 2023 Grand National. 16 April The Sunday Mail publishes leaked video purporting to show Nicola Sturgeon playing down concerns about the SNP's finances. The SNP says that its finances are "in balance" following reports the party is facing a financial crisis. 18 April – SNP treasurer Colin Beattie is arrested and questioned by Police Scotland in connection with their ongoing investigation into the party's finances. 19 April – Colin Beattie resigns as SNP treasurer with immediate effect. 22 April – Police Scotland make several arrests at Ayr Racecourse as the protest group Animal Rising attempts to disrupt the Scottish Grand National by invading the course.
Inhibitory postsynaptic potential (IPSP) A type of synaptic potential that makes a neuron less likely to fire an action potential, usually by allowing chloride or potassium ions to enter the cell. Innervation The supply of nerves to a specific body part. In neuroscience, it describes how neurons connect to and control muscles, glands, or other neurons. Input resistance A measure of how much a neuron's membrane resists incoming current. It influences how strongly the cell responds to synaptic inputs. Insular cortex A region buried within the lateral sulcus, involved in interoception, emotion, taste, and awareness of bodily states. Intelligence quotient (IQ) A standardized measure of cognitive ability. In neuroscience, research explores how brain structure and function relate to individual differences in IQ. Interneuron A neuron that connects other neurons within a neural circuit, typically within the same brain region or spinal segment. Often inhibitory and essential for reflexes and signal modulation. Intracranial pressure The pressure inside the skull, exerted by brain tissue, blood, and cerebrospinal fluid. Abnormal levels can cause headaches, vision problems, or brain damage. Intracellular recording A technique used to measure the voltage or current inside a neuron, providing detailed information about membrane potential and ionic currents. Ion channel A pore-forming membrane protein that allows ions to pass in and out of neurons. Ion channels are critical for generating and propagating electrical signals.
The Scottish Government reaffirms its wish to see the Gender Recognition Reform (Scotland) Bill enacted. 11 May – Scotland's warmest day of the year so far is recorded by the Met Office, with a temperature of 25.7 °C at Cassley. 13 May – At the High Court in Kilmarnock, Uber driver Kunathilinghan Mohanthas is sentenced to seven years in prison for killing Christopher Hanton, who he left for dead in Glasgow city centre after ordering him out of his car and knocking him over as he performed a three-point turn in August 2023. 14 May – MSPs unanimously approve the Housing Cladding Remediation Bill with 116 votes in favour of the legislation that seeks to address problems with cladding on buildings and avoid a similar incident to the Grenfell Tower fire in Scotland. 15 May – The Scottish Government declares a national housing emergency during a parliamentary debate at Holyrood, citing UK government budget cuts and austerity as the reasons for a shortage in housing. Justice Secretary Angela Constance confirms that the Scottish Government are to seek powers to facilitate the early release of prisoners in order to prevent overcrowding in prisons. The rules would only apply to those serving under four years and would not apply to those convicted of sexual or domestic violence related offences. 18 May – Four police officers are injured and 19 arrests made in Glasgow city centre as fans celebrate after Celtic win the Premiership.
Adiponectin Resistin Plasminogen activator inhibitor-1 (PAI-1) TNFα IL-6 Leptin Estradiol (E2) Adipose tissues also secrete a type of cytokines (cell-to-cell signalling proteins) called adipokines (adipose cytokines), which play a role in obesity-associated complications. Perivascular adipose tissue releases adipokines such as adiponectin that affect the contractile function of the vessels that they surround.
Sources: en.wikipedia.org
It is a synthetic peptide analog of angiotensin IV studied mainly in laboratory and animal research. It is not an approved medicine. Human clinical data are limited.
It is generally not regulated as a dietary supplement. Products are often sold as research chemicals. That status affects purity, labeling, and legal availability.
Dihexa itself is not a standard endogenous peptide. It is synthesized and modeled on angiotensin IV. Angiotensin IV occurs naturally as a fragment of angiotensin II.
Dihexa is a synthetic peptide-like compound studied in preclinical research. It is often described as an angiotensin IV analog, but it is not an approved medicine. Public information comes mainly from laboratory work and commercial listings.